The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOld Mutual Lim. Regulatory News (OMU)

Share Price Information for Old Mutual Lim. (OMU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 47.15
Bid: 46.50
Ask: 47.55
Change: -1.10 (-2.28%)
Spread: 1.05 (2.258%)
Open: 47.60
High: 47.90
Low: 46.70
Prev. Close: 48.25
OMU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Voluntary Trading Statement

13 Sep 2023 07:00

RNS Number : 2118M
Old Mutual Limited
13 September 2023
 

Old Mutual Limited

Incorporated in the Republic of South Africa

Registration number: 2017/235138/06

ISIN: ZAE000255360

LEI: 213800MON84ZWWPQCN47

JSE Share Code: OMU

LSE Share Code: OMU

NSX Share Code: OMM

MSE Share Code: OMU

ZSE Share Code: OMU

("Old Mutual" or "Company" or "Group")

 

Ref 49/23

13 September 2023

 

OLD MUTUAL VOLUNTARY TRADING STATEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023

 

Investors are advised that Old Mutual is currently in the process of finalising its interim results for the six months ended 30 June 2023 ("current period"), which will be released on the Stock Exchange News Service of the JSE Limited on Wednesday, 27 September 2023. The current period results are prepared on an IFRS 17 basis whereas the interim results for the six months ended 30 June 2022 ("comparative period") were prepared on an IFRS 4 basis. The release of our results will be accompanied by an IFRS 17 bridging pack providing H1 2022 and FY 2022 comparative numbers on both an IFRS 4 and IFRS 17 basis. We have attached Annexure A hereto which provides an extract from our bridging pack on H1 2022 comparatives for:

· our key profit measures, namely results from operations and adjusted headline earnings; and

· IFRS profit after tax attributable to equity holders of the parent and headline earnings.

 

This trading statement provides an indication of a range for headline earnings per ordinary share (HEPS) and earnings attributable to equity holders of the Group per ordinary share (EPS) in terms of paragraph 3.4(b) of the JSE Limited Listings Requirements compared to the comparative period on an IFRS 17 basis.

 

The ranges provided in this trading statement are relative to the IFRS 17 results for the comparative period. It is not expected that results will differ by more than 20% compared to previously disclosed comparative period results under IFRS 4.

 

Investors are advised that the Group's key profit measures are expected to be within the ranges outlined below:

 

Key Performance Indicators

(R million unless stated otherwise)

 

Estimated

% change

 

Estimated

30 June 2023

IFRS 17 Unaudited

results for the six months

ended

30 June 2022

Results from operations

 

-7%-13%

 

3 939 - 4 790

 

4 254

Adjusted headline earnings (AHE)

 

13%-33%

 

2 901 - 3 417

 

2 579

Adjusted headline earnings per share (AHEPS) (cents)¹

 

11%-31%

 

63.2 - 74.5

56.8

 

1 AHEPS is defined as AHE divided by the weighted average number of ordinary shares (WANS) adjusted to reflect the Group's B-BBEE shares.

 

We expect results from operations to be within the range of -7% to +13% due to good operational performance which was dampened by continued adverse persistency with short term persistency provisions raised in our Mass and Foundation Cluster segment.

 

We expect adjusted headline earnings to be above 20% relative to the comparative period due to an increase in shareholder investment return as a result of increased interest rates and a recovery in equity markets.

 

Headline earnings per share (HEPS) and basic earnings per share (EPS) are expected to fall within the ranges outlined below:

 

Key Performance Indicators

(R million unless stated otherwise)

 

Estimated

% change

 

Estimated

30 June 2023

IFRS 17 Unaudited

results for six months

ended 30 June 2022

IFRS profit after tax attributable to equity holders of the parent

-20% - 0%

3 869 - 4 836

4 831

Basic EPS (cents)

-19% - 1%

86.0 - 107.4

106.8

Headline earnings

-18% - 2%

3 884 - 4 834

4 749

HEPS (cents)

-18% - 2%

86.3 - 107.3

104.9

 

Headline earnings is higher than adjusted headline earnings, as adjusted headline earnings exclude earnings from operations in Zimbabwe and adjustments for accounting mismatches. Accounting mismatches include hedging mismatch losses arising from the transition of the guaranteed product related hedging programs to IFRS 17.  This impact is expected to significantly reduce in future reporting periods as the hedging mismatch has been largely resolved and the hedging strategies are materially aligned with IFRS 17 positions.

 

The financial information in this trading statement is the responsibility of the Old Mutual Limited Board of Directors and has not been reviewed or reported on by the Group's external auditors.

 

Sandton

 

Sponsors

JSE

Merrill Lynch South Africa (Pty) Limited t/a BofA Securities

Namibia

PSG Wealth Management (Namibia) (Proprietary) Limited

Zimbabwe

Imara Capital Zimbabwe plc

Malawi

Stockbrokers Malawi Limited

 

 

Enquiries

 

Investor Relations

Bonga Mriga

Interim Head of Investor Relations

 

 

M: +27 67 866 6348

E: investorrelations@oldmutual.com

 

Communications

 

Tabby Tsengiwe

General Manager: Public Affairs

M: +27 60 547 4947

E: oldmutualnews@oldmutual.com 

 

Notes to Editors

About Old Mutual Limited

Old Mutual is a premium African financial services group that offers a broad spectrum of financial solutions to retail and corporate customers across key market segments in 14 countries. Old Mutual's primary operations are in Africa, and it has a niche business in China. With over 178 years of heritage across sub-Saharan Africa, Old Mutual is a crucial part of the communities it serves as well as broader society on the continent.

 

For further information on Old Mutual and its underlying businesses, please visit the corporate website at www.oldmutual.com.

 

 

 

ANNEXURE A

Extract from IFRS 17 Bridging pack for the half year ended 30 June 2022

H1 2022 Comparatives on an IFRS 4 and IFRS 17 basis

 

Supplementary Income Statement

H1 2022

Rm

IFRS 17

IFRS 4

Mass and Foundation Cluster

1 341

1 583

Personal Finance and Wealth Management

1 538

1 259

Old Mutual Investments

 566

 566

Old Mutual Corporate

 806

 727

Old Mutual Insure

 323

 213

Old Mutual Africa Regions

 166

 212

Net expenses from central functions

(486)

(463)

Results from operations

 4 254

4 097

Shareholder investment return2

 205

 415

Finance costs

(330)

(330)

Income from associates1

20

20

Adjusted headline earnings before tax and non-controlling interests

 4 149

4 202

Shareholder tax

(1 447)

(1 375)

Non-controlling interests

(123)

(136)

Adjusted headline earnings

2 579

2 691

 

 

Reconciliation of AHE to IFRS profit after tax

H1 2022

Rm

IFRS 17

IFRS 4

Adjusted headline earnings

2 579

2 691

Accounting mismatches and hedging impacts

49

 606

Impact of restructuring

 31

 31

Operations in hyperinflationary economies

2 023

1 745

Residual plc

 67

 67

Headline earnings

4 749

5 140

Impairment of goodwill, other intangible assets and property

 24

 24

Reversal of impairment of investments in associated undertakings

(32)

(32)

Loss on disposal of subsidiaries and associated undertakings

 90

 90

IFRS profit after tax attributable to ordinary equity holders of the parent

4 831

5 222

 

Per Share measures (cents)

H1 2022

 

IFRS 17

IFRS 4

Adjusted headline earnings per share

56.8

59.2

Headline earnings per share

104.9

116.3

Basic earnings per share

106.8

118.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUUVVRORUKAAR
Date   Source Headline
13th Feb 202411:00 amRNSForm 8.3 - Mondi Plc
2nd Jan 20243:00 pmRNSDealings in securities on behalf of Share Trusts
27th Dec 20233:00 pmRNSDealings in securities on behalf of ESIS
21st Dec 20233:00 pmRNSChange of the JSE Equity Sponsor
20th Dec 20233:30 pmRNSDealings in securities on behalf of ESIS
19th Dec 20233:30 pmRNSSecurities dealings on behalf of ESIS
12th Dec 20233:45 pmRNSChange in JSE equity sponsor
5th Dec 20233:45 pmRNSDirectorate Change
5th Dec 20233:00 pmRNSDirector/PDMR Shareholding
30th Nov 202311:00 amRNSDirector/PDMR Shareholding
22nd Nov 20238:00 amRNSOld Mutual Limited Voluntary Operating Update
9th Nov 20233:00 pmRNSDirector/PDMR Shareholding
31st Oct 20233:00 pmRNSDirector/PDMR Shareholding
26th Oct 20234:30 pmRNSOld Mutual Share Repurchase programme
25th Oct 20234:30 pmRNSDealings in securities on behalf of ESIS
20th Oct 20234:00 pmRNSDealings in securities on behalf of ESIS
17th Oct 20232:30 pmRNSDealing in securities on behalf of ESIS
3rd Oct 20239:00 amRNSFinalisation and dividend currency equivalents
27th Sep 20237:00 amRNSUnaudited Interim Results and Dividend Declaration
13th Sep 20237:00 amRNSVoluntary Trading Statement
28th Jul 20237:00 amRNSInvestor update and release of information
30th May 202310:00 amRNSOld Mutual Share Repurchase Programme
30th May 20237:00 amRNSResult of AGM
26th May 20231:00 pmRNSForm 8.3 - Mediclinic International plc
25th May 202311:40 amRNSVoluntary Operating Update
18th May 20231:30 pmRNSForm 8.3 - Mediclinic International plc
11th May 20231:00 pmRNSForm 8.3 - Mediclinic International plc
4th May 20231:45 pmRNSForm 8.3 - Mediclinic International plc
27th Apr 20232:00 pmRNSForm 8.3 - Mediclinic International plc
25th Apr 20233:30 pmRNSNotice of AGM and no change statement
24th Apr 202311:00 amRNSDirector/PDMR Shareholding
21st Apr 20231:45 pmRNSForm 8.3 - [Mediclinic International plc]
19th Apr 20234:00 pmRNSDirector/PDMR Shareholding
14th Apr 202311:00 amRNSRelease of Integrated Report & Investor Engagement
13th Apr 202312:30 pmRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSForm 8.3 - [Mediclinic International plc]
6th Apr 20234:40 pmRNSDirector/PDMR Shareholding
6th Apr 20232:45 pmRNSDealings in securities on behalf of ESIS
6th Apr 202310:30 amRNSForm 8.3 - [Mediclinic International plc]
5th Apr 202311:00 amRNSForm 8.3 - [Mediclinic International plc]
4th Apr 20232:00 pmRNSForm 8.3 - [Mediclinic International plc]
4th Apr 20231:00 pmRNSDealings in securities on behalf of ESOP
4th Apr 20239:00 amRNSOML BEE certificate and annual compliance report
31st Mar 20232:30 pmRNSDealings in Securities on behalf of Share Trusts
30th Mar 202312:15 pmRNSForm 8.3 - [Mediclinic International plc]
29th Mar 20232:30 pmRNSDealings in securities on behalf of share trusts
27th Mar 20234:15 pmRNSDealings in securities on behalf of a share trust
24th Mar 20237:00 amRNSNo change statement
22nd Mar 20238:00 amRNSFINALISATION AND DIVIDEND CURRENCY EQUIVALENTS
17th Mar 20234:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.